YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2

Using the practical randomized controlled trial designed by Zelen, the subjects were randomly divided into the experimental group and the control group. The experimental group was given the traditional Chinese medicine prescription ' Shenzhuo Decoction ' ( composed of Astragalus membranaceus, Salvia miltiorrhiza, Leech, Raw Rhubarb, Epimedium, Motherwort ) + basic treatment ( including nutrition, lifestyle, hypoglycemic, hypotensive, lipid-lowering, control of other risk factors, etc. ), the control group was given basic treatment, a total of 1 year of drug intervention, followed up for 1 year.

NCT Number	NCT07034807
Lead Sponsor	Liu Hongfang Collaborators: Guang'anmen Hospital，China Academy of Chinese Medical Sciencescancel, First Affiliated Hospital, Sun Yat-Sen University, Tianjin Medical University, Affiliated Hospital of Changchun University of Chinese Medicine, EFONG PHARMRCEUTICRL
Conditions	Diabetic Kidney Disease (DKD)
Enrollment	228 participants
Start Date	2025-08-01
Primary Completion	2028-07-31 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2025-06-24